APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hospital and Nursing Home Probiotics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Hospital and Nursing Home Probiotics Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchHospital and Nursing Home Probiotics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Hospital and Nursing Home Probiotics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Hospital and Nursing Home Probiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hospital and Nursing Home Probiotics Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Hospital and Nursing Home Probiotics Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Hospital and Nursing Home Probiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Hospital and Nursing Home Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hospital and Nursing Home Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hospital and Nursing Home Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Hospital and Nursing Home Probiotics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Hospital and Nursing Home Probiotics market include American Lifeline, Becton Dickinson and Company, Bio - K Plus International, Eva Nutra, Mercola, Nebraska Cultures, Nutraceutix, NutraScience Labs and Probium, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hospital and Nursing Home Probiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hospital and Nursing Home Probiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hospital and Nursing Home Probiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hospital and Nursing Home Probiotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Hospital and Nursing Home Probiotics Segment by Company

American Lifeline

Becton Dickinson and Company

Bio - K Plus International

Eva Nutra

Mercola

Nebraska Cultures

Nutraceutix

NutraScience Labs

Probium

Protexin

Rising Pharmaceuticals

UP4 Probiotics

Vitakem Nutraceuticals

Hospital and Nursing Home Probiotics Segment by Type

Gram-positive Cocci

Lactobacillus

Bifidobacterium

Others

Hospital and Nursing Home Probiotics Segment by Application

Immunity

Wellness

Gut Health

Others

Hospital and Nursing Home Probiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hospital and Nursing Home Probiotics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hospital and Nursing Home Probiotics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hospital and Nursing Home Probiotics significant trends, drivers, influence factors in global and regions.

6. To analyze Hospital and Nursing Home Probiotics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital and Nursing Home Probiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hospital and Nursing Home Probiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital and Nursing Home Probiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hospital and Nursing Home Probiotics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hospital and Nursing Home Probiotics industry.

Chapter 3: Detailed analysis of Hospital and Nursing Home Probiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hospital and Nursing Home Probiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hospital and Nursing Home Probiotics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hospital and Nursing Home Probiotics Industry Trends Table 2. Hospital and Nursing Home Probiotics Industry Drivers Table 3. Hospital and Nursing Home Probiotics Industry Opportunities and Challenges Table 4. Hospital and Nursing Home Probiotics Industry Restraints Table 5. Global Hospital and Nursing Home Probiotics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hospital and Nursing Home Probiotics Revenue Share by Company (2021-2026) Table 7. Global Hospital and Nursing Home Probiotics Sales Volume by Company (k units) & (2021-2026) Table 8. Global Hospital and Nursing Home Probiotics Sales Volume Share by Company (2021-2026) Table 9. Global Hospital and Nursing Home Probiotics Average Price (US$/unit) of Company (2021-2026) Table 10. Global Hospital and Nursing Home Probiotics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hospital and Nursing Home Probiotics Key Company Manufacturing Base & Headquarters Table 12. Global Hospital and Nursing Home Probiotics Company, Product Type & Application Table 13. Global Hospital and Nursing Home Probiotics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hospital and Nursing Home Probiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Gram-positive Cocci Table 18. Significant Companies of Lactobacillus Table 19. Significant Companies of Bifidobacterium Table 20. Significant Companies of Others Table 21. Global Hospital and Nursing Home Probiotics Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Hospital and Nursing Home Probiotics Sales Volume by Type (2021-2026) & (k units) Table 23. Global Hospital and Nursing Home Probiotics Sales Volume by Type (2027-2032) & (k units) Table 24. Global Hospital and Nursing Home Probiotics Sales Volume Share by Type (2021-2026) Table 25. Global Hospital and Nursing Home Probiotics Sales Volume Share by Type (2027-2032) Table 26. Global Hospital and Nursing Home Probiotics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Hospital and Nursing Home Probiotics Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Hospital and Nursing Home Probiotics Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Hospital and Nursing Home Probiotics Sales Value Share by Type (2021-2026) Table 30. Global Hospital and Nursing Home Probiotics Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Immunity Table 32. Significant Companies of Wellness Table 33. Significant Companies of Gut Health Table 34. Significant Companies of Others Table 35. Global Hospital and Nursing Home Probiotics Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Hospital and Nursing Home Probiotics Sales Volume by Application (2021-2026) & (k units) Table 37. Global Hospital and Nursing Home Probiotics Sales Volume by Application (2027-2032) & (k units) Table 38. Global Hospital and Nursing Home Probiotics Sales Volume Share by Application (2021-2026) Table 39. Global Hospital and Nursing Home Probiotics Sales Volume Share by Application (2027-2032) Table 40. Global Hospital and Nursing Home Probiotics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Hospital and Nursing Home Probiotics Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Hospital and Nursing Home Probiotics Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Hospital and Nursing Home Probiotics Sales Value Share by Application (2021-2026) Table 44. Global Hospital and Nursing Home Probiotics Sales Value Share by Application (2027-2032) Table 45. Global Hospital and Nursing Home Probiotics Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Hospital and Nursing Home Probiotics Sales by Region (2021-2026) & (k units) Table 47. Global Hospital and Nursing Home Probiotics Sales Market Share by Region (2021-2026) Table 48. Global Hospital and Nursing Home Probiotics Sales by Region (2027-2032) & (k units) Table 49. Global Hospital and Nursing Home Probiotics Sales Market Share by Region (2027-2032) Table 50. Global Hospital and Nursing Home Probiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Hospital and Nursing Home Probiotics Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Hospital and Nursing Home Probiotics Sales Value Share by Region (2021-2026) Table 53. Global Hospital and Nursing Home Probiotics Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Hospital and Nursing Home Probiotics Sales Value Share by Region (2027-2032) Table 55. Global Hospital and Nursing Home Probiotics Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Hospital and Nursing Home Probiotics Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Hospital and Nursing Home Probiotics Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Hospital and Nursing Home Probiotics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Hospital and Nursing Home Probiotics Sales by Country (2021-2026) & (k units) Table 60. Global Hospital and Nursing Home Probiotics Sales Market Share by Country (2021-2026) Table 61. Global Hospital and Nursing Home Probiotics Sales by Country (2027-2032) & (k units) Table 62. Global Hospital and Nursing Home Probiotics Sales Market Share by Country (2027-2032) Table 63. Global Hospital and Nursing Home Probiotics Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Hospital and Nursing Home Probiotics Sales Value Market Share by Country (2021-2026) Table 65. Global Hospital and Nursing Home Probiotics Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Hospital and Nursing Home Probiotics Sales Value Market Share by Country (2027-2032) Table 67. American Lifeline Company Information Table 68. American Lifeline Business Overview Table 69. American Lifeline Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. American Lifeline Hospital and Nursing Home Probiotics Product Portfolio Table 71. American Lifeline Recent Development Table 72. Becton Dickinson and Company Company Information Table 73. Becton Dickinson and Company Business Overview Table 74. Becton Dickinson and Company Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Becton Dickinson and Company Hospital and Nursing Home Probiotics Product Portfolio Table 76. Becton Dickinson and Company Recent Development Table 77. Bio - K Plus International Company Information Table 78. Bio - K Plus International Business Overview Table 79. Bio - K Plus International Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Bio - K Plus International Hospital and Nursing Home Probiotics Product Portfolio Table 81. Bio - K Plus International Recent Development Table 82. Eva Nutra Company Information Table 83. Eva Nutra Business Overview Table 84. Eva Nutra Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Eva Nutra Hospital and Nursing Home Probiotics Product Portfolio Table 86. Eva Nutra Recent Development Table 87. Mercola Company Information Table 88. Mercola Business Overview Table 89. Mercola Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Mercola Hospital and Nursing Home Probiotics Product Portfolio Table 91. Mercola Recent Development Table 92. Nebraska Cultures Company Information Table 93. Nebraska Cultures Business Overview Table 94. Nebraska Cultures Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Nebraska Cultures Hospital and Nursing Home Probiotics Product Portfolio Table 96. Nebraska Cultures Recent Development Table 97. Nutraceutix Company Information Table 98. Nutraceutix Business Overview Table 99. Nutraceutix Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Nutraceutix Hospital and Nursing Home Probiotics Product Portfolio Table 101. Nutraceutix Recent Development Table 102. NutraScience Labs Company Information Table 103. NutraScience Labs Business Overview Table 104. NutraScience Labs Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. NutraScience Labs Hospital and Nursing Home Probiotics Product Portfolio Table 106. NutraScience Labs Recent Development Table 107. Probium Company Information Table 108. Probium Business Overview Table 109. Probium Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Probium Hospital and Nursing Home Probiotics Product Portfolio Table 111. Probium Recent Development Table 112. Protexin Company Information Table 113. Protexin Business Overview Table 114. Protexin Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Protexin Hospital and Nursing Home Probiotics Product Portfolio Table 116. Protexin Recent Development Table 117. Rising Pharmaceuticals Company Information Table 118. Rising Pharmaceuticals Business Overview Table 119. Rising Pharmaceuticals Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Rising Pharmaceuticals Hospital and Nursing Home Probiotics Product Portfolio Table 121. Rising Pharmaceuticals Recent Development Table 122. UP4 Probiotics Company Information Table 123. UP4 Probiotics Business Overview Table 124. UP4 Probiotics Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. UP4 Probiotics Hospital and Nursing Home Probiotics Product Portfolio Table 126. UP4 Probiotics Recent Development Table 127. Vitakem Nutraceuticals Company Information Table 128. Vitakem Nutraceuticals Business Overview Table 129. Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Product Portfolio Table 131. Vitakem Nutraceuticals Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Hospital and Nursing Home Probiotics Distributors List Table 135. Hospital and Nursing Home Probiotics Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Hospital and Nursing Home Probiotics Product Image Figure 2. Global Hospital and Nursing Home Probiotics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hospital and Nursing Home Probiotics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hospital and Nursing Home Probiotics Sales (2021-2032) & (k units) Figure 5. Global Hospital and Nursing Home Probiotics Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Hospital and Nursing Home Probiotics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gram-positive Cocci Image Figure 10. Lactobacillus Image Figure 11. Bifidobacterium Image Figure 12. Others Image Figure 13. Global Hospital and Nursing Home Probiotics Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Hospital and Nursing Home Probiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Hospital and Nursing Home Probiotics Sales Volume Share by Type (2021-2032) Figure 16. Global Hospital and Nursing Home Probiotics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Hospital and Nursing Home Probiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Hospital and Nursing Home Probiotics Sales Value Share by Type (2021-2032) Figure 19. Immunity Image Figure 20. Wellness Image Figure 21. Gut Health Image Figure 22. Others Image Figure 23. Global Hospital and Nursing Home Probiotics Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Hospital and Nursing Home Probiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Hospital and Nursing Home Probiotics Sales Volume Share by Application (2021-2032) Figure 26. Global Hospital and Nursing Home Probiotics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Hospital and Nursing Home Probiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Hospital and Nursing Home Probiotics Sales Value Share by Application (2021-2032) Figure 29. Global Hospital and Nursing Home Probiotics Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Hospital and Nursing Home Probiotics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Hospital and Nursing Home Probiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Hospital and Nursing Home Probiotics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Hospital and Nursing Home Probiotics Sales Value (2021-2032) & (US$ Million) Figure 34. North America Hospital and Nursing Home Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Hospital and Nursing Home Probiotics Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Hospital and Nursing Home Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Hospital and Nursing Home Probiotics Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Hospital and Nursing Home Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Hospital and Nursing Home Probiotics Sales Value (2021-2032) & (US$ Million) Figure 40. South America Hospital and Nursing Home Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Hospital and Nursing Home Probiotics Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Hospital and Nursing Home Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Hospital and Nursing Home Probiotics Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Hospital and Nursing Home Probiotics Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Gram-positive Cocci
  • Lactobacillus
  • Bifidobacterium
  • Others
Applications
  • Immunity
  • Wellness
  • Gut Health
  • Others
Companies covered
  • American Lifeline
  • Becton Dickinson and Company
  • Bio - K Plus International
  • Eva Nutra
  • Mercola
  • Nebraska Cultures
  • Nutraceutix
  • NutraScience Labs
  • Probium
  • Protexin
  • Rising Pharmaceuticals
  • UP4 Probiotics
  • Vitakem Nutraceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hospital and Nursing Home Probiotics Sales Value (2021-2032)
  4. 1.2.2 Global Hospital and Nursing Home Probiotics Sales Volume (2021-2032)
  5. 1.2.3 Global Hospital and Nursing Home Probiotics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hospital and Nursing Home Probiotics Market Dynamics
  1. 2.1 Hospital and Nursing Home Probiotics Industry Trends
  2. 2.2 Hospital and Nursing Home Probiotics Industry Drivers
  3. 2.3 Hospital and Nursing Home Probiotics Industry Opportunities and Challenges
  4. 2.4 Hospital and Nursing Home Probiotics Industry Restraints
3 Hospital and Nursing Home Probiotics Market by Company
  1. 3.1 Global Hospital and Nursing Home Probiotics Company Revenue Ranking in 2025
  2. 3.2 Global Hospital and Nursing Home Probiotics Revenue by Company (2021-2026)
  3. 3.3 Global Hospital and Nursing Home Probiotics Sales Volume by Company (2021-2026)
  4. 3.4 Global Hospital and Nursing Home Probiotics Average Price by Company (2021-2026)
  5. 3.5 Global Hospital and Nursing Home Probiotics Company Ranking (2024-2026)
  6. 3.6 Global Hospital and Nursing Home Probiotics Company Manufacturing Base and Headquarters
  7. 3.7 Global Hospital and Nursing Home Probiotics Company Product Type and Application
  8. 3.8 Global Hospital and Nursing Home Probiotics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hospital and Nursing Home Probiotics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hospital and Nursing Home Probiotics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hospital and Nursing Home Probiotics Market by Type
  1. 4.1 Hospital and Nursing Home Probiotics Type Introduction
  2. 4.1.1 Gram-positive Cocci
  3. 4.1.2 Lactobacillus
  4. 4.1.3 Bifidobacterium
  5. 4.1.4 Others
  6. 4.2 Global Hospital and Nursing Home Probiotics Sales Volume by Type
  7. 4.2.1 Global Hospital and Nursing Home Probiotics Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Hospital and Nursing Home Probiotics Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Hospital and Nursing Home Probiotics Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Hospital and Nursing Home Probiotics Sales Value by Type
  11. 4.3.1 Global Hospital and Nursing Home Probiotics Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Hospital and Nursing Home Probiotics Sales Value by Type (2021-2032)
  13. 4.3.3 Global Hospital and Nursing Home Probiotics Sales Value Share by Type (2021-2032)
5 Hospital and Nursing Home Probiotics Market by Application
  1. 5.1 Hospital and Nursing Home Probiotics Application Introduction
  2. 5.1.1 Immunity
  3. 5.1.2 Wellness
  4. 5.1.3 Gut Health
  5. 5.1.4 Others
  6. 5.2 Global Hospital and Nursing Home Probiotics Sales Volume by Application
  7. 5.2.1 Global Hospital and Nursing Home Probiotics Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Hospital and Nursing Home Probiotics Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Hospital and Nursing Home Probiotics Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Hospital and Nursing Home Probiotics Sales Value by Application
  11. 5.3.1 Global Hospital and Nursing Home Probiotics Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Hospital and Nursing Home Probiotics Sales Value by Application (2021-2032)
  13. 5.3.3 Global Hospital and Nursing Home Probiotics Sales Value Share by Application (2021-2032)
6 Hospital and Nursing Home Probiotics Regional Sales and Value Analysis
  1. 6.1 Global Hospital and Nursing Home Probiotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hospital and Nursing Home Probiotics Sales by Region (2021-2032)
  3. 6.2.1 Global Hospital and Nursing Home Probiotics Sales by Region: 2021-2026
  4. 6.2.2 Global Hospital and Nursing Home Probiotics Sales by Region (2027-2032)
  5. 6.3 Global Hospital and Nursing Home Probiotics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hospital and Nursing Home Probiotics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hospital and Nursing Home Probiotics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hospital and Nursing Home Probiotics Sales Value by Region (2027-2032)
  9. 6.5 Global Hospital and Nursing Home Probiotics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hospital and Nursing Home Probiotics Sales Value (2021-2032)
  12. 6.6.2 North America Hospital and Nursing Home Probiotics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hospital and Nursing Home Probiotics Sales Value (2021-2032)
  15. 6.7.2 Europe Hospital and Nursing Home Probiotics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hospital and Nursing Home Probiotics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hospital and Nursing Home Probiotics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hospital and Nursing Home Probiotics Sales Value (2021-2032)
  21. 6.9.2 South America Hospital and Nursing Home Probiotics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hospital and Nursing Home Probiotics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hospital and Nursing Home Probiotics Sales Value Share by Country, 2025 VS 2032
7 Hospital and Nursing Home Probiotics Country-level Sales and Value Analysis
  1. 7.1 Global Hospital and Nursing Home Probiotics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hospital and Nursing Home Probiotics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hospital and Nursing Home Probiotics Sales by Country (2021-2032)
  4. 7.3.1 Global Hospital and Nursing Home Probiotics Sales by Country (2021-2026)
  5. 7.3.2 Global Hospital and Nursing Home Probiotics Sales by Country (2027-2032)
  6. 7.4 Global Hospital and Nursing Home Probiotics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hospital and Nursing Home Probiotics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hospital and Nursing Home Probiotics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hospital and Nursing Home Probiotics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hospital and Nursing Home Probiotics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hospital and Nursing Home Probiotics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 American Lifeline
  2. 8.1.1 American Lifeline Company Information
  3. 8.1.2 American Lifeline Business Overview
  4. 8.1.3 American Lifeline Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 American Lifeline Hospital and Nursing Home Probiotics Product Portfolio
  6. 8.1.5 American Lifeline Recent Developments
  7. 8.2 Becton Dickinson and Company
  8. 8.2.1 Becton Dickinson and Company Company Information
  9. 8.2.2 Becton Dickinson and Company Business Overview
  10. 8.2.3 Becton Dickinson and Company Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Becton Dickinson and Company Hospital and Nursing Home Probiotics Product Portfolio
  12. 8.2.5 Becton Dickinson and Company Recent Developments
  13. 8.3 Bio - K Plus International
  14. 8.3.1 Bio - K Plus International Company Information
  15. 8.3.2 Bio - K Plus International Business Overview
  16. 8.3.3 Bio - K Plus International Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bio - K Plus International Hospital and Nursing Home Probiotics Product Portfolio
  18. 8.3.5 Bio - K Plus International Recent Developments
  19. 8.4 Eva Nutra
  20. 8.4.1 Eva Nutra Company Information
  21. 8.4.2 Eva Nutra Business Overview
  22. 8.4.3 Eva Nutra Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Eva Nutra Hospital and Nursing Home Probiotics Product Portfolio
  24. 8.4.5 Eva Nutra Recent Developments
  25. 8.5 Mercola
  26. 8.5.1 Mercola Company Information
  27. 8.5.2 Mercola Business Overview
  28. 8.5.3 Mercola Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mercola Hospital and Nursing Home Probiotics Product Portfolio
  30. 8.5.5 Mercola Recent Developments
  31. 8.6 Nebraska Cultures
  32. 8.6.1 Nebraska Cultures Company Information
  33. 8.6.2 Nebraska Cultures Business Overview
  34. 8.6.3 Nebraska Cultures Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nebraska Cultures Hospital and Nursing Home Probiotics Product Portfolio
  36. 8.6.5 Nebraska Cultures Recent Developments
  37. 8.7 Nutraceutix
  38. 8.7.1 Nutraceutix Company Information
  39. 8.7.2 Nutraceutix Business Overview
  40. 8.7.3 Nutraceutix Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nutraceutix Hospital and Nursing Home Probiotics Product Portfolio
  42. 8.7.5 Nutraceutix Recent Developments
  43. 8.8 NutraScience Labs
  44. 8.8.1 NutraScience Labs Company Information
  45. 8.8.2 NutraScience Labs Business Overview
  46. 8.8.3 NutraScience Labs Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 NutraScience Labs Hospital and Nursing Home Probiotics Product Portfolio
  48. 8.8.5 NutraScience Labs Recent Developments
  49. 8.9 Probium
  50. 8.9.1 Probium Company Information
  51. 8.9.2 Probium Business Overview
  52. 8.9.3 Probium Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Probium Hospital and Nursing Home Probiotics Product Portfolio
  54. 8.9.5 Probium Recent Developments
  55. 8.10 Protexin
  56. 8.10.1 Protexin Company Information
  57. 8.10.2 Protexin Business Overview
  58. 8.10.3 Protexin Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Protexin Hospital and Nursing Home Probiotics Product Portfolio
  60. 8.10.5 Protexin Recent Developments
  61. 8.11 Rising Pharmaceuticals
  62. 8.11.1 Rising Pharmaceuticals Company Information
  63. 8.11.2 Rising Pharmaceuticals Business Overview
  64. 8.11.3 Rising Pharmaceuticals Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Rising Pharmaceuticals Hospital and Nursing Home Probiotics Product Portfolio
  66. 8.11.5 Rising Pharmaceuticals Recent Developments
  67. 8.12 UP4 Probiotics
  68. 8.12.1 UP4 Probiotics Company Information
  69. 8.12.2 UP4 Probiotics Business Overview
  70. 8.12.3 UP4 Probiotics Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 UP4 Probiotics Hospital and Nursing Home Probiotics Product Portfolio
  72. 8.12.5 UP4 Probiotics Recent Developments
  73. 8.13 Vitakem Nutraceuticals
  74. 8.13.1 Vitakem Nutraceuticals Company Information
  75. 8.13.2 Vitakem Nutraceuticals Business Overview
  76. 8.13.3 Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Product Portfolio
  78. 8.13.5 Vitakem Nutraceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hospital and Nursing Home Probiotics Value Chain Analysis
  2. 9.1.1 Hospital and Nursing Home Probiotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hospital and Nursing Home Probiotics Sales Mode & Process
  6. 9.2 Hospital and Nursing Home Probiotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hospital and Nursing Home Probiotics Distributors
  9. 9.2.3 Hospital and Nursing Home Probiotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst